4,205
Views
30
CrossRef citations to date
0
Altmetric
Review

A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines

, , &
Pages 1095-1105 | Received 16 Mar 2017, Accepted 19 Sep 2017, Published online: 03 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Pierre Bakhache, Vijay Yewale, Raunak Parikh, Gabriella Clancey, Gemma Spickernell, Valérie Berlaimont & Elisa Turriani. (2022) Diphtheria-tetanus-pertussis (DTP) vaccination: understanding the perspectives and expectations of parents and healthcare professionals in France and India. Human Vaccines & Immunotherapeutics 18:1.
Read now
Julianne Bayliss, Michael Nissen, Damita Prakash, Peter Richmond, Kyu-Bin Oh & Terry Nolan. (2021) Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine. Human Vaccines & Immunotherapeutics 17:1, pages 176-190.
Read now
Mary Slack, Susanna Esposito, Hervé Haas, Attila Mihalyi, Michael Nissen, Piyali Mukherjee & Lauriane Harrington. (2020) Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication. Expert Review of Vaccines 19:10, pages 903-917.
Read now
Victor Romanenko, Irina Osipova, Anna Galustyan, Michael Scherbakov, Nathalie Baudson, Déborah Farhi, Luis Anaya, Sherine O. Kuriyakose, Nadia Meyer & Winnie Janssens. (2020) Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study. Human Vaccines & Immunotherapeutics 16:9, pages 2265-2273.
Read now
Ivonne Puente Gómez, Céline Verheust, Linda Hanssens & Jan Dolhain. (2020) Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance. Expert Review of Vaccines 19:8, pages 771-779.
Read now
Manel Ben Fredj, Wafa Dhouib, Meriem Kacem, Cyrine Bennasrallah, Ons Mehrez, Hela Abroug, Imen Zemni, Aicha Gardabou, Koubaa Jamel, Slaheddine Chouchene, Naceur Rouatbi & Asma Belguith Sriha. (2020) Trends and health burden of hospitalized acute respiratory infections and impact of Haemophilus influenza immunization in a Tunisian university hospital: a twelve-year study. Libyan Journal of Medicine 15:1.
Read now
Farshid Jalalvand & Kristian Riesbeck. (2018) Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. Expert Review of Vaccines 17:6, pages 503-512.
Read now

Articles from other publishers (22)

Sean Patrick Fitzwater, Geoffrey D. Kahn, Aruna Chandran & Mathuram Santosham. 2023. Plotkin's Vaccines. Plotkin's Vaccines 348 364.e9 .
Michael D. Decker, Barbara J. Howe, David P. Greenberg & Kathryn M. Edwards. 2023. Plotkin's Vaccines. Plotkin's Vaccines 225 247.e13 .
Janice Seinfeld, María Laura Rosales, Alfredo Sobrevilla & Juan Guillermo López Yescas. (2022) Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru. BMC Health Services Research 22:1.
Crossref
Anna Carrera-Salinas, Aida González-Díaz, Laura Calatayud, Julieta Mercado-Maza, Carmen Puig, Dàmaris Berbel, Jordi Càmara, Fe Tubau, Imma Grau, M. Ángeles Domínguez, Carmen Ardanuy & Sara Martí. (2021) Epidemiology and population structure of Haemophilus influenzae causing invasive disease. Microbial Genomics 7:12.
Crossref
Lisa R. McTaggart, Kirby Cronin, Chi Yon Seo, Sarah Wilson, Samir N. Patel & Julianne V. Kus. (2021) Increased Incidence of Invasive Haemophilus influenzae Disease Driven by Non-Type B Isolates in Ontario, Canada, 2014 to 2018. Microbiology Spectrum 9:2.
Crossref
Markus Knuf, Hervé Haas, Pilar Garcia-Corbeira, Elisa Turriani, Piyali Mukherjee, Winnie Janssens & Valérie Berlaimont. (2021) Hexavalent vaccines: What can we learn from head-to-head studies?. Vaccine 39:41, pages 6025-6036.
Crossref
Janet R Gilsdorf. (2021) Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease . The Journal of Infectious Diseases 224:Supplement_4, pages S321-S330.
Crossref
Sedigheh Rafiei Tabatabaei, Sara Mohammadzadeh, Seyed Mohsen Zahraei, Sussan Mahmoudi, Ghazaleh Ghandchi, Seyedeh Mahsan Hoseini-Alfatemi, Abdollah Karimi & Ahmadreza Shamshiri. (2021) Effect of Haemophilus influenzae Type b Vaccination on Nasopharyngeal Carriage Rate in Children, Tehran, 2019. BioMed Research International 2021, pages 1-6.
Crossref
María Eugenia León, Aníbal Kawabata, Minako Nagai, Liliana Rojas, Gustavo Chamorro, Noemí Zárate, Gloria Gómez, Myrian Leguizamón, Juan Irala, Juana Ortellado, Rossana Franco & Nancy Segovia. (2021) Epidemiologic study of Haemophilus influenzae causing invasive and non-invasive disease in Paraguay (1999–2017). Enfermedades infecciosas y microbiologia clinica (English ed.) 39:2, pages 59-64.
Crossref
María Eugenia León, Aníbal Kawabata, Minako Nagai, Liliana Rojas, Gustavo Chamorro, Noemí Zárate, Gloria Gómez, Myrian Leguizamón, Juan Irala, Juana Ortellado, Rossana Franco & Nancy Segovia. (2021) Estudio epidemiológico de Haemophilus influenzae causante de enfermedad invasiva y no invasiva en Paraguay (1999-2017). Enfermedades Infecciosas y Microbiología Clínica 39:2, pages 59-64.
Crossref
Taito Kitano & Hirosato Aoki. (2021) A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan. Vaccine 39:2, pages 343-349.
Crossref
Federico Martinón-Torres. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations 207 222 .
Mary P. E. Slack. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations 195 206 .
Emin Umit Bagriacik. 2021. Nanotechnology Applications in Health and Environmental Sciences. Nanotechnology Applications in Health and Environmental Sciences 291 298 .
Yoshito Nishimura, Hideharu Hagiya, Kaoru Kawano, Yuya Yokota, Kosuke Oka, Koji Iio, Kou Hasegawa, Mikako Obika, Tomoko Haruma, Sawako Ono, Hisashi Masuyama & Fumio Otsuka. (2020) Invasive non-typeable Haemophilus influenzae infection due to endometritis associated with adenomyosis. BMC Infectious Diseases 20:1.
Crossref
Catarina Isabel Moreira Heliodoro, Célia Rodrigues Bettencourt & Maria Paula Bajanca-Lavado. (2020) Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011–2018. European Journal of Clinical Microbiology & Infectious Diseases 39:8, pages 1471-1480.
Crossref
Silvia Ricci, Clementina Canessa, Lorenzo Lodi, Mattia Giovannini, Francesca Lippi, Maria Moriondo, Francesco Nieddu & Chiara Azzari. (2020) Invasive Haemophilus influenzae Type b Disease in the Post Hexavalent Era. Pediatric Infectious Disease Journal 39:4, pages 294-297.
Crossref
Danila Elango & Benjamin L. Schulz. (2019) Phase-Variable Glycosylation in Nontypeable Haemophilus influenzae . Journal of Proteome Research 19:1, pages 464-476.
Crossref
Hannah M. Rowe, Beth Mann, Amy Iverson, Aaron Poole, Elaine Tuomanen & Jason W. Rosch. (2019) A Cross-Reactive Protein Vaccine Combined with PCV-13 Prevents Streptococcus pneumoniae- and Haemophilus influenzae-Mediated Acute Otitis Media. Infection and Immunity 87:10.
Crossref
Gunnar Dahlen, Amina Basic & Johan Bylund. (2019) Importance of Virulence Factors for the Persistence of Oral Bacteria in the Inflamed Gingival Crevice and in the Pathogenesis of Periodontal Disease. Journal of Clinical Medicine 8:9, pages 1339.
Crossref
Susana Monge, Susan JM Hahné, Hester E de Melker, Elisabeth AM Sanders, Arie van der Ende & Mirjam J Knol. (2018) Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003–16): a case-control study. The Lancet Infectious Diseases 18:7, pages 749-757.
Crossref
Matthijs C. Brouwer & Diederik van de Beek. (2018) Epidemiology of community-acquired bacterial meningitis. Current Opinion in Infectious Diseases 31:1, pages 78-84.
Crossref